为癌症免疫疗法而设计的树突细胞衍生的细胞外囊泡
Margarida Oliveira Coelho1, Sofia Torres Quintas1, Bruno Sarmento2
1i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, Porto 4200-135, Portugal; INEB - Instituto de Engenharia Biomédica, Universidade do Porto, Rua Alfredo Allen 208, 4200- 180 Porto, Portugal; ICBAS - Instituto de Ciências Biomédicas de Abel Salazar, Universidade do Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal.
细胞外囊泡 (EVs),特别是那些来自树突细胞 (DC-EVs) 的细胞外囊泡,显示出对无细胞免疫疗法的希望. 这些电动汽车的工程增强了它们对癌症疫苗和免疫反应调节的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
- 细胞生物学 细胞生物学
背景情况:
- 细胞外囊泡 (EVs) 正在成为无细胞疗法,因为它们的生物相容性和调解细胞间通信的能力.
- 树突细胞衍生的细胞外囊泡 (DC-EVs) 特别有希望,它们携带抗原和免疫调节因子,可以激活T细胞.
研究的目的:
- 审查工程DC-EV的进步,以加强免疫疗法.
- 讨论DC-EVs在癌症疫苗和免疫调节中的潜力.
主要方法:
- 对DC-EV工程策略的当前文献的审查.
- 对DC-EV载荷和表面分子功能的分析.
- 讨论基于DC-EV的疗法的挑战.
主要成果:
- 设计的DC-EV可以装载瘤特异性抗原和细胞因子,以提高免疫治疗潜力.
- DC-EVs通过MHC和共刺激因子等表面分子促进T细胞激活.
- 为了改善治疗结果,EV可以被制成疫苗.
结论:
- 工程DC-EV提供了一种有前途的策略,以提高免疫治疗的安全性和有效性.
- 需要进一步的研究来解决DC-EV疗法的临床转化方面的挑战.
更多相关视频
08:50Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
12:43Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Published on: January 6, 2014
相关概念视频
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
